LOUIS G LANGE
CIK 1238401 · EVP Cardiovascular Therapeutic · last filed 2026-03-12
LOUIS G LANGE is an EVP Cardiovascular Therapeutic who has filed 70 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $1.4M of NAMSW on Mar 12, 2026. Across all open-market trades the lifetime net is −$20.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $839.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$839.9K
6
70
-$20.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Director | 10,360 | $18.80 | $194.8K | -$2.09M | 10 | 2026-03-12 |
| BOLD | Director | 0 | $1.41 | $0 | -$9.35M | 19 | 2020-01-15 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 2 | 2015-06-30 |
| ESPR | Director | 204,803 | $3.15 | $645.1K | $199.0K | 1 | 2013-07-01 |
| GILD | EVP Cardiovascular Therapeutic | — | $125.59 | — | $0 | 2 | 2009-05-08 |
| CV THERAPEUTICS INC (CVTX) Delisted | Chairman & CEO | 490,432 | — | — | -$9.54M | 25 | 2009-04-17 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | NAMSW | Sell (S) | −44,619 | -$1.36M | EDGAR |
| 2026-03-10 | NAMSW | Mixed | +16,433 | -$315.8K | EDGAR |
| 2026-01-09 | NAMSW | Grant (A) | +3,400 | $0 | EDGAR |
| 2025-06-03 | NAMSW | Exer (M) | +68 | $0 | EDGAR |
| 2025-05-02 | NAMSW | Exer (M) | +69 | $0 | EDGAR |
| 2025-04-21 | NAMSW | Exer (M) | +69 | $0 | EDGAR |
| 2025-03-28 | NAMSW | Mixed | +3,102 | $0 | EDGAR |
| 2025-01-08 | NAMSW | Grant (A) | +6,960 | $0 | EDGAR |
| 2024-02-21 | NAMSW | Buy (P) | +5,000 | $95.0K | EDGAR |
| 2024-01-03 | NAMSW | Grant (A) | — | $0 | EDGAR |